A Randomized, Placebo-Controlled, Double-Blind, Crossover, Single-Dose Exposure Study to Evaluate the Early Bronchodilating Effect of FlutiForm 100/10 microg HFA pMDI and FlutiForm 250/10 microg HFA pMDI, Compared to Placebo in Adult Subjects With Mild to Moderate Asthma.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2010
At a glance
- Drugs Formoterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors SkyePharma AG
- 11 Dec 2008 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 11 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Sep 2008 New trial record.